Arch Cardiovasc Dis
December 2024
Arch Cardiovasc Dis
December 2024
Background: Peripheral arterial diseases (PADs) account for much of the morbidity and hospitalizations experienced by patients with cardiovascular disease. Epidemiological data on these diseases are lacking in France.
Aims: To describe the epidemiology of aortic diseases (aneurysm and dissection) and PADs in France in 2022.
Background: Demographic changes and improvements in the diagnosis and treatment of valvular heart diseases (VHDs) have led to changes in its epidemiological profile.
Aims: To describe the epidemiology of VHD in France in 2022.
Methods: Adults hospitalized due to VHD in 2022 were identified from the French National Health Data System and categorized by type of VHD on the basis of hospital diagnoses and interventions.
Background: Few epidemiological data are available for venous thromboembolism (VTE) at French national and subnational levels.
Aims: To quantify VTE events in France in 2022 and describe the features of hospital management and outcomes.
Methods: Adults hospitalized for a VTE as the primary reason for hospitalization or treatment in a medical unit in 2022 were identified from medical administrative data.